{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:14:26Z","timestamp":1787170466160,"version":"build-2736575974"},"reference-count":38,"publisher":"American Chemical Society (ACS)","issue":"17","license":[{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T00:00:00Z","timestamp":1749513600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/100031789","name":"Central Council for Research in Ayurvedic Sciences, Ministry of AYUSH, Government of India","doi-asserted-by":"publisher","award":["GAP-3144"],"award-info":[{"award-number":["GAP-3144"]}],"id":[{"id":"10.13039\/100031789","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["IIRPSG-2024-01-04443"],"award-info":[{"award-number":["IIRPSG-2024-01-04443"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council\u00c2\u00a0of\u00c2\u00a0Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["GAP3104"],"award-info":[{"award-number":["GAP3104"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council\u00c2\u00a0of\u00c2\u00a0Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["GAP-3107"],"award-info":[{"award-number":["GAP-3107"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001412","name":"Council\u00c2\u00a0of\u00c2\u00a0Scientific and Industrial Research, India","doi-asserted-by":"publisher","award":["HCP-41"],"award-info":[{"award-number":["HCP-41"]}],"id":[{"id":"10.13039\/501100001412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Department of Science and Technology, Ministry of Science and Technology","doi-asserted-by":"publisher","award":["GAP2181"],"award-info":[{"award-number":["GAP2181"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Department of Science and Technology, Ministry of Science and Technology","doi-asserted-by":"publisher","award":["SRG\/2022\/001567"],"award-info":[{"award-number":["SRG\/2022\/001567"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001852","name":"Indo-French Centre for the Promotion of Advanced Research","doi-asserted-by":"publisher","award":["GAP-3130"],"award-info":[{"award-number":["GAP-3130"]}],"id":[{"id":"10.13039\/501100001852","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The eternal battle against Tuberculosis necessitates the discovery of novel drugs. This study outlines identification of novel quinoline and quinazoline series through phenotypic screening of the ChemDiv library against Mtb-H37Rv. The potency, mode of inhibition, and structure\u2013activity relationships around the confirmed actives are described. Both series disclosed potent anti-TB activity against drug-sensitive and drug-resistant strains. The quinazoline series exhibited cytotoxicity toward eukaryotic cells, while the quinoline compounds were both active and noncytotoxic. Among the quinoline compounds, the most promising molecule, IIIM-IDD-Q1b, exhibited an IC90 of 9.7 \u03bcg\/mL, with no observed cytotoxicity, resulting in a high safety index (&amp;gt;10). It demonstrated potent intracellular inhibition against Mtb as made evident by fluorescence imaging and CFU enumeration. Mode-of-action studies revealed that quinoline compounds target DNA gyrase, while quinazoline series target ATP synthase. Overall, both series demonstrate promising biological properties and a favorable pharmacokinetic profile. Further medicinal chemistry optimization could enhance and boost the anti-TB potency of the identified compounds.<\/jats:p>","DOI":"10.1021\/acs.jmedchem.4c02568","type":"journal-article","created":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T14:55:39Z","timestamp":1749567339000},"page":"18178-18196","source":"Crossref","is-referenced-by-count":4,"title":["Keeping Up\nwith the Q\u2019s: Mechanistic Insights\nand Validation of Quinoline and Quinazoline Scaffolds as Potent Drugs\nagainst Tuberculosis"],"prefix":"10.1021","volume":"68","author":[{"given":"Anjali","family":"Negi","sequence":"first","affiliation":[{"name":"CSIR-Indian Institute of Integrative Medicine , , ,","place":["Jammu, India, 180001"]},{"name":"Academy of Scientific and Innovative Research (AcSIR) , ,","place":["Ghaziabad, India, 201002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Summaya","family":"Perveen","sequence":"additional","affiliation":[{"name":"CSIR-Indian Institute of Integrative Medicine , , ,","place":["Jammu, India, 180001"]},{"name":"Academy of Scientific and Innovative Research (AcSIR) , ,","place":["Ghaziabad, India, 201002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harpreet","family":"Kour","sequence":"additional","affiliation":[{"name":"CSIR-Indian Institute of Integrative Medicine , , ,","place":["Jammu, India, 180001"]},{"name":"Academy of Scientific and Innovative Research (AcSIR) , ,","place":["Ghaziabad, India, 201002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvinder Pal","family":"Singh","sequence":"additional","affiliation":[{"name":"CSIR-Indian Institute of Integrative Medicine , , ,","place":["Jammu, India, 180001"]},{"name":"Academy of Scientific and Innovative Research (AcSIR) , ,","place":["Ghaziabad, India, 201002"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0686-7126","authenticated-orcid":true,"given":"Rashmi","family":"Sharma","sequence":"additional","affiliation":[{"name":"CSIR-Indian Institute of Integrative Medicine , , ,","place":["Jammu, India, 180001"]},{"name":"Academy of Scientific and Innovative Research (AcSIR) , ,","place":["Ghaziabad, India, 201002"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2025,6,10]]},"reference":[{"key":"2026073102110026100_cit1","doi-asserted-by":"publisher","first-page":"116058","DOI":"10.1016\/j.ejmech.2023.116058","article-title":"The Significance of Persisters in Tuberculosis Drug\nDiscovery: Exploring the Potential of Targeting the Glyoxylate Shunt\nPathway","volume":"265","author":"Negi","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"2026073102110026100_cit2","doi-asserted-by":"crossref","DOI":"10.54394\/CJQU6666","volume-title":"Global Tuberculosis Report 2024","author":"World Health Organization.","year":"2024"},{"issue":"4","key":"2026073102110026100_cit3","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1021\/acs.jmedchem.3c01892","article-title":"Unraveling\nDilemmas and Lacunae in the Escalating Drug Resistance of Mycobacterium\nTuberculosis to Bedaquiline, Delamanid, and Pretomanid","volume":"67","author":"Negi","year":"2024","journal-title":"J. Med. Chem."},{"issue":"11","key":"2026073102110026100_cit4","doi-asserted-by":"publisher","first-page":"7489","DOI":"10.1021\/acs.jmedchem.2c00227","article-title":"Tuberculosis\nDrug Discovery: Challenges and New Horizons","volume":"65","author":"Fernandes","year":"2022","journal-title":"J. Med. Chem."},{"key":"2026073102110026100_cit5","doi-asserted-by":"publisher","first-page":"114906","DOI":"10.1016\/j.bcp.2021.114906","article-title":"Screening Approaches and Therapeutic\nTargets: The Two\nDriving Wheels of Tuberculosis Drug Discovery","volume":"197","author":"Perveen","year":"2022","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"2026073102110026100_cit6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205479","article-title":"A High-Throughput Whole\nCell Screen to Identify Inhibitors\nof Mycobacterium Tuberculosis","volume":"14","author":"Ollinger","year":"2019","journal-title":"PLoS One"},{"issue":"1","key":"2026073102110026100_cit7","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12866-021-02212-3","article-title":"A High-Throughput Screening Assay\nBased on Automated Microscopy for\nMonitoring Antibiotic Susceptibility of Mycobacterium Tuberculosis\nPhenotypes","volume":"21","author":"Kalsum","year":"2021","journal-title":"BMC Microbiol."},{"issue":"19","key":"2026073102110026100_cit8","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1002\/cmdc.201900217","article-title":"Integrated\nTarget-Based\nand Phenotypic Screening Approaches for the Identification of Anti-Tubercular\nAgents That Bind to the Mycobacterial Adenylating Enzyme MbtA","volume":"14","author":"Ferguson","year":"2019","journal-title":"ChemMedChem"},{"issue":"2","key":"2026073102110026100_cit9","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1021\/acsinfecdis.3c00463","article-title":"Identification\nof Chemical Scaffolds Targeting Drug-Resistant and Latent Mycobacterium\nTuberculosis through High-Throughput Whole-Cell Screening","volume":"10","author":"Perveen","year":"2024","journal-title":"ACS Infect. Dis."},{"issue":"8","key":"2026073102110026100_cit10","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.biopha.2014.10.007","article-title":"Quinoline: A Promising Antitubercular\nTarget","volume":"68","author":"Keri","year":"2014","journal-title":"Biomed. Pharmacother."},{"key":"2026073102110026100_cit11","doi-asserted-by":"publisher","first-page":"101986","DOI":"10.1016\/j.tube.2020.101986","article-title":"Recent Advances in\nthe Synthesis of Quinazoline Analogues as Anti-TB\nAgents","volume":"124","author":"Dutta","year":"2020","journal-title":"Tuberculosis"},{"issue":"8","key":"2026073102110026100_cit12","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1021\/acsmedchemlett.2c00254","article-title":"Antitubercular\nActivity of Novel 2-(Quinoline-4-Yloxy)Acetamides with Improved Drug-Like\nProperties","volume":"13","author":"Borsoi","year":"2022","journal-title":"ACS Med. Chem. Lett."},{"key":"2026073102110026100_cit13","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1021\/acsmedchemlett.3c00570","article-title":"Exploring Scaffold Hopping\nfor Novel 2-(Quinolin-4-Yloxy)Acetamides\nwith Enhanced Antimycobacterial Activity","volume":"15","author":"Borsoi","year":"2024","journal-title":"ACS\nMed. Chem. Lett."},{"issue":"1","key":"2026073102110026100_cit14","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s43094-019-0016-7","article-title":"Synthesis and Biological Evaluation\nof Some 4-Aminoquinoline\nDerivatives as Potential Antitubercular Agents","volume":"6","author":"Alegaon","year":"2020","journal-title":"Future J. Pharm. Sci."},{"key":"2026073102110026100_cit15","doi-asserted-by":"publisher","first-page":"107705","DOI":"10.1016\/j.bioorg.2024.107705","article-title":"Identification\nof Antimycobacterial 8-Hydroxyquinoline Derivatives as in Vitro Enzymatic\nInhibitors of Mycobacterium Tuberculosis Enoyl-Acyl Carrier Protein\nReductase","volume":"151","author":"Joaquim","year":"2024","journal-title":"Bioorg. Chem."},{"issue":"3","key":"2026073102110026100_cit16","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1021\/acsmedchemlett.5b00324","article-title":"2-(Quinolin-4-Yloxy)Acetamides Are\nActive against Drug-Susceptible and Drug-Resistant Mycobacterium Tuberculosis\nStrains","volume":"7","author":"Pissinate","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"issue":"4","key":"2026073102110026100_cit17","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s11094-011-0598-7","article-title":"Synthesis\nand Antituberculous Activity of Quinoline Isosteres of Isoniazid","volume":"45","author":"Zimichev","year":"2011","journal-title":"Pharm. Chem. J."},{"key":"2026073102110026100_cit18","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2174\/1573406415666190904124630","article-title":"Novel Furan Coupled Quinoline Diamide Hybrid Scaffolds\nas Potent Antitubercular Agents: Design, Synthesis and Molecular Modelling","volume":"16","author":"Rajpurohit","year":"2020","journal-title":"Med. Chem."},{"key":"2026073102110026100_cit19","doi-asserted-by":"publisher","first-page":"112996","DOI":"10.1016\/j.ejmech.2020.112996","article-title":"Synthesis\nand Evaluation of New Quinazoline-Benzimidazole Hybrids as Potent\nAnti-Microbial Agents against Multidrug Resistant Staphylococcus Aureus\nand Mycobacterium Tuberculosis","volume":"212","author":"Malasala","year":"2021","journal-title":"Eur. J. Med.\nChem."},{"issue":"9","key":"2026073102110026100_cit20","doi-asserted-by":"publisher","first-page":"4413","DOI":"10.1021\/acsabm.2c00562","article-title":"Design and Synthesis\nof Quinazolinone-Triazole Hybrids as Potent\nAnti-Tubercular Agents","volume":"5","author":"Dutta","year":"2022","journal-title":"ACS Appl. Bio Mater."},{"issue":"6","key":"2026073102110026100_cit21","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1021\/acsinfecdis.4c00277","article-title":"Confronting\nTuberculosis: A Synthetic Quinoline-Isonicotinic Acid Hydrazide Hybrid\nCompound as a Potent Lead Molecule Against Mycobacterium Tuberculosis","volume":"10","author":"Vadankula","year":"2024","journal-title":"ACS Infect. Dis."},{"key":"2026073102110026100_cit22","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.ejmech.2018.03.076","article-title":"An Overview\nof Quinazolines: Pharmacological Significance\nand Recent Developments","volume":"151","author":"Alagarsamy","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"21","key":"2026073102110026100_cit23","doi-asserted-by":"publisher","first-page":"14724","DOI":"10.1021\/acs.jmedchem.3c01273","article-title":"Dual Inhibition\nof Mycobacterium\nTuberculosis and the Host TGFBR1 by an Anilinoquinazoline","volume":"66","author":"Nandakumar","year":"2023","journal-title":"J. Med. Chem."},{"issue":"9","key":"2026073102110026100_cit24","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1016\/j.bmc.2015.03.004","article-title":"Design and Synthesis\nof Novel Quinoline\u2013Aminopiperidine Hybrid Analogues as Mycobacterium\nTuberculosis DNA gyraseB Inhibitors","volume":"23","author":"Medapi","year":"2015","journal-title":"Bioorg.\nMed. Chem."},{"issue":"14","key":"2026073102110026100_cit25","doi-asserted-by":"publisher","first-page":"11632","DOI":"10.3390\/ijms241411632","article-title":"Mycobacterium\nTuberculosis Inhibitors Based on Arylated Quinoline Carboxylic Acid\nBackbones with Anti-Mtb Gyrase Activity","volume":"24","author":"Quimque","year":"2023","journal-title":"Int.\nJ. Mol. Sci."},{"issue":"5","key":"2026073102110026100_cit26","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1039\/C5MD00589B","article-title":"Scaffold Morphing\nLeading to Evolution of 2,4-Diaminoquinolines and Aminopyrazolopyrimidines\nas Inhibitors of the ATP Synthesis Pathway","volume":"7","author":"Tantry","year":"2016","journal-title":"MedChemComm"},{"issue":"3","key":"2026073102110026100_cit27","doi-asserted-by":"publisher","first-page":"106385","DOI":"10.1016\/j.ijantimicag.2021.106385","article-title":"Whole-Genome\nAnalysis\nof Drug-Resistant Mycobacterium Tuberculosis Reveals Novel Mutations\nAssociated with Fluoroquinolone Resistance","volume":"58","author":"Chaiyachat","year":"2021","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"1","key":"2026073102110026100_cit28","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202013207","article-title":"Dual Inhibition of the Terminal Oxidases Eradicates Antibiotic-tolerant\nMycobacterium Tuberculosis","volume":"13","author":"Lee","year":"2021","journal-title":"EMBO Mol. Med."},{"issue":"6","key":"2026073102110026100_cit29","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02282-23","article-title":"GaMF1.39\u2019s Antibiotic Efficacy and Its Enhanced\nAntitubercular Activity in Combination with Clofazimine, Telacebec,\nND-011992, or TBAJ-876","volume":"11","author":"Ragunathan","year":"2023","journal-title":"Microbiol. Spectrum"},{"key":"2026073102110026100_cit30","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.tube.2017.10.008","article-title":"Screening of Antitubercular\nCompound Library Identifies Novel ATP Synthase Inhibitors of Mycobacterium\nTuberculosis","volume":"108","author":"Kumar","year":"2018","journal-title":"Tuberculosis"},{"issue":"5","key":"2026073102110026100_cit31","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00018-22","article-title":"Anti-Mycobacterium\nAbscessus Activity\nof Tuberculosis F-ATP Synthase Inhibitor GaMF1","volume":"66","author":"Ragunathan","year":"2022","journal-title":"Antimicrob. Agents Chemother."},{"issue":"10","key":"2026073102110026100_cit32","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01191-19","article-title":"TBAJ-876 Retains Bedaquiline\u2019s\nActivity against Subunits c and \u03b5 of Mycobacterium Tuberculosis\nF-ATP Synthase","volume":"63","author":"Sarathy","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"2026073102110026100_cit33","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/nprot.2006.478","article-title":"Organelle\nIsolation: Functional Mitochondria\nfrom Mouse Liver, Muscle and Cultured Filroblasts","volume":"2","author":"Frezza","year":"2007","journal-title":"Nat. Protoc."},{"issue":"3","key":"2026073102110026100_cit34","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1128\/AAC.01393-08","article-title":"Selectivity of TMC207 towards Mycobacterial ATP Synthase Compared\nwith That towards the Eukaryotic Homologue","volume":"53","author":"Haagsma","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"2026073102110026100_cit35","doi-asserted-by":"publisher","first-page":"107702","DOI":"10.1016\/j.bioorg.2024.107702","article-title":"N-Acyl Phenothiazines as Mycobacterial\nATP Synthase Inhibitors: Rational Design, Synthesis and in Vitro Evaluation\nagainst Drug Sensitive, RR and MDR-TB","volume":"151","author":"Reddyrajula","year":"2024","journal-title":"Bioorg.\nChem."},{"key":"2026073102110026100_cit36","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s42250-020-00162-3","article-title":"In-Silico Molecular\nDocking and ADME\/Pharmacokinetic\nPrediction Studies of Some Novel Carboxamide Derivatives as Anti-Tubercular\nAgents","volume":"3","author":"Abdullahi","year":"2020","journal-title":"Chem. Afr."},{"issue":"12","key":"2026073102110026100_cit37","doi-asserted-by":"publisher","first-page":"10276","DOI":"10.1074\/jbc.M110.200501","article-title":"Reduction of Clofazimine\nby Mycobacterial Type 2 NADH:Quinone Oxidoreductase","volume":"286","author":"Yano","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"10","key":"2026073102110026100_cit38","doi-asserted-by":"publisher","first-page":"4150","DOI":"10.1128\/AAC.00821-10","article-title":"Simple Model for Testing Drugs against\nNonreplicating Mycobacterium Tuberculosis","volume":"54","author":"Sala","year":"2010","journal-title":"Antimicrob.\nAgents Chemother."}],"container-title":["Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jmedchem.4c02568","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/68\/17\/18178\/66294644\/acs.jmedchem.4c02568.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article-pdf\/68\/17\/18178\/66294644\/acs.jmedchem.4c02568.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T06:11:08Z","timestamp":1785478268000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jmcmar\/article\/68\/17\/18178\/5234776\/Keeping-Up-with-the-Q-s-Mechanistic-Insights-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,10]]},"references-count":38,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2025,6,10]]},"published-print":{"date-parts":[[2025,9,11]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jmedchem.4c02568","relation":{},"ISSN":["0022-2623","1520-4804"],"issn-type":[{"value":"0022-2623","type":"print"},{"value":"1520-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,10]]}}}